Literature DB >> 5638113

[Recurrent hypoglycemic coma due to abnormal degradation of tolbutamide].

E Schulz, W Brinkmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5638113     DOI： 10.1055/s-0028-1105094

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN： 0012-0472            Impact factor:   0.628


× No keyword cloud information.
  6 in total

Review 1.  [The pathogenesis of hepatogenic diabetes mellitus].

Authors:  K Kopetz
Journal:  Klin Wochenschr       Date:  1970-11-01

2.  [On the forensic evaluation of hypoglycemia during treatment with oral anti-diabetics].

Authors:  E Böhm
Journal:  Dtsch Z Gesamte Gerichtl Med       Date:  1968

3.  [Influence of liver diseases and kidney function disorders and phenylbutazone, phenprocoumarol and doxycycline on the excretion of glycodiazine].

Authors:  H Held; B Kaminski; H F von Oldershausen
Journal:  Diabetologia       Date:  1970-08       Impact factor: 10.122

4.  The metabolism of tolbutamide and cyclamate.

Authors:  P Glogner
Journal:  Humangenetik       Date:  1970

5.  [Metabolic changes following glucose and tolbutamide loading in liver cirrhosis and their role in the pathogenesis of hepatogenic diabetes mellitus].

Authors:  K Kopetz; P Wehrmann
Journal:  Klin Wochenschr       Date:  1970-11-01

6.  [Treatment of maturity-onset diabetics with tobultamide i.v. during operations].

Authors:  H Schmitt; H Liebermeister; G Lo Sardo; H Daweke
Journal:  Diabetologia       Date:  1968-11       Impact factor: 10.122
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.